SMARCA4 and non-small cell lung carcinoma: This study aims to retrospectively analyze the prognostic impact on survival outcomes of KRAS-mutated and SMARCA4 (class 1 and 2) mutated or KRAS/SMARCA4 co-mutations in NSCLC patients via the AACR GENIE BPC dataset.